跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,274 条关于
“KRRO-121”
全部
5,274
临床试验
2,476
药物
2,017
机构
11
资讯
770
6个月前
Korro Bio Advances RNA Editing Platform with KRRO-121 Nomination and $85 Million Financing
10个月前
Korro Bio's RNA Editing Drug Shows Promise but Falls Short of Efficacy Targets in Alpha-1 Antitrypsin Deficiency Trial
去年
Korro Bio's KRRO-110 Receives Green Light in Australia for AATD Trial
去年
Korro Bio Receives EMA Orphan Drug Designation for RNA Editing Therapy KRRO-110 in Alpha-1 Antitrypsin Deficiency
2年前
FDA Extends Review Timeline for REGENXBIO's Hunter Syndrome Gene Therapy RGX-121
2年前
RGX-121 Gene Therapy Shows Sustained Efficacy in Hunter Syndrome Trial
去年
UK Government Commits £121 Million to Revitalize Clinical Trial Sector Following O'Shaughnessy Review
10个月前
Korro Bio Abandons Lead RNA Editing Drug After Clinical Disappointment, Cuts 34% of Staff
去年
Merrimack Pharmaceuticals Advances Oncology Pipeline with MM-398 and MM-121
16天前
Treeline and Roche Collaborate on Phase 1 Trial of BCL6 Degrader TLN-121 Combined with CD20×CD3 Bispecifics in B-Cell Lymphomas
第 1 页,共 77 页
上一页
下一页